Industry Presentations

Acute Lymphoblastic Leukemia (ALL)


  • NON

    A treatment option for Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL): A Case-based Discussion

    Speakers:Vinod Pullarkat, MDLori Muffly, MD

    Duration: 60 minutes

    Presented on: July 15, 2021

    *This session is not eligible for AMA PRA Category 1 CreditsTM


  • Vinod Pullarkat, MD

    Vinod Pullarkat, MD

    Vinod Pullarkat, MD

    Vinod A. Pullarkat, MD, MRCP is Clinical Professor of Hematology and Hematopoietic Cell Transplantation at City of Hope. Dr. Pullarkat’s research interests include treatment of acute leukemia, stem cell transplantation, bone marrow failure and autoimmune hematologic disorders. His basic research focuses on new drug development for acute leukemia. Dr. Pullarkat has authored over 125 scientific articles in various peer reviewed journals and he serves as principal investigator for multiple clinical trials at City of Hope.
  • Lori Muffly, MD

    Lori Muffly, MD

    Lori Muffly, MD

    Dr. Lori Muffly is an Assistant Professor of Medicine specializing in Blood and Marrow Transplantation and Cellular Therapy. Dr. Muffly’s clinical research focuses on optimizing access to care and therapeutic approaches for adults with acute leukemias. She is the Principal Investigator on a number of multi-center clinical trials and has received grant funding and several awards for her work in acute lymphoblastic leukemia and transplantation.